Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The Src-Family Kinases Hck, Fgr and Lyn Drive Immune Complex-Mediated Glomerulonephritis Through the Syk Tyrosine Kinase.

Created on 15 Aug 2026

Authors

Lukács S Lesinszki, Dorottya Deli, Lili K Boldizsár, Áron Pánczél, Attila Fintha, Michael G Robson, Attila Mócsai

Published in

FASEB journal : official publication of the Federation of American Societies for Experimental Biology. Volume 40. Issue 16. Pages e72190. Aug 31, 2026.

Abstract

While immune complex-mediated glomerulonephritis causes severe kidney dysfunction in diseases like lupus nephritis, the signaling pathways involved are poorly understood. Here we tested the role of the Src-family kinases Hck, Fgr and Lyn, primarily expressed in innate immune cells, in immune complex-mediated glomerulonephritis. Hck, Fgr and Lyn expression increased in human lupus nephritis, as well as in mouse nephrotoxic nephritis triggered by sheep antiserum against mouse glomerular components (nephrotoxic serum). Nephrotoxic serum induced robust albuminuria, serum creatinine level increase, hematuria and ascites in wild-type but not in Hck-/-Fgr-/-Lyn-/- mice. The Hck-/-Fgr-/-Lyn-/- mutation also abrogated crescent formation and leukocyte infiltration. However, the glomerular IgG/complement deposition and the humoral immune response against sheep IgG were not affected. Transplantation of Hck-/-Fgr-/-Lyn-/- bone marrow cells transferred disease protection to wild-type recipients. Mixed bone marrow chimeric experiments revealed an indirect role for Hck, Fgr and Lyn in leukocyte recruitment. Src-family kinases mediated immune complex-induced activation of Syk, a recently proposed therapeutic target. Our results suggest that myeloid Src-family kinases are indispensable for nephrotoxic nephritis. Inhibitors targeting those kinases may provide therapeutic benefit in immune complex-mediated glomerulonephritis.

PMID:
42599887
Bibliographic data and abstract were imported from PubMed on 15 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement